423 related articles for article (PubMed ID: 27799330)
1. Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.
Rogovskyy AS; Gillis DC; Ionov Y; Gerasimov E; Zelikovsky A
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27799330
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes.
McDowell JV; Sung SY; Hu LT; Marconi RT
Infect Immun; 2002 Aug; 70(8):4196-203. PubMed ID: 12117928
[TBL] [Abstract][Full Text] [Related]
3. New Zealand White Rabbits Effectively Clear Borrelia burgdorferi B31 despite the Bacterium's Functional
Batool M; Hillhouse AE; Ionov Y; Kochan KJ; Mohebbi F; Stoica G; Threadgill DW; Zelikovsky A; Waghela SD; Wiener DJ; Rogovskyy AS
Infect Immun; 2019 Jul; 87(7):. PubMed ID: 30988058
[No Abstract] [Full Text] [Related]
4. YebC regulates variable surface antigen VlsE expression and is required for host immune evasion in Borrelia burgdorferi.
Zhang Y; Chen T; Raghunandanan S; Xiang X; Yang J; Liu Q; Edmondson DG; Norris SJ; Yang XF; Lou Y
PLoS Pathog; 2020 Oct; 16(10):e1008953. PubMed ID: 33048986
[TBL] [Abstract][Full Text] [Related]
5. Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
Batool M; Caoili SEC; Dangott LJ; Gerasimov E; Ionov Y; Piontkivska H; Zelikovsky A; Waghela SD; Rogovskyy AS
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866906
[TBL] [Abstract][Full Text] [Related]
6. Delineating Surface Epitopes of Lyme Disease Pathogen Targeted by Highly Protective Antibodies of New Zealand White Rabbits.
Rogovskyy AS; Caoili SEC; Ionov Y; Piontkivska H; Skums P; Tsyvina V; Zelikovsky A; Waghela SD
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31085705
[TBL] [Abstract][Full Text] [Related]
7. Detailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection.
Coutte L; Botkin DJ; Gao L; Norris SJ
PLoS Pathog; 2009 Feb; 5(2):e1000293. PubMed ID: 19214205
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Importance of VlsE Antigenic Variation for the Enzootic Cycle of Borrelia burgdorferi.
Rogovskyy AS; Casselli T; Tourand Y; Jones CR; Owen JP; Mason KL; Scoles GA; Bankhead T
PLoS One; 2015; 10(4):e0124268. PubMed ID: 25893989
[TBL] [Abstract][Full Text] [Related]
9. Variable VlsE is critical for host reinfection by the Lyme disease spirochete.
Rogovskyy AS; Bankhead T
PLoS One; 2013; 8(4):e61226. PubMed ID: 23593438
[TBL] [Abstract][Full Text] [Related]
10. Antigenicity and recombination of VlsE, the antigenic variation protein of Borrelia burgdorferi, in rabbits, a host putatively resistant to long-term infection with this spirochete.
Embers ME; Liang FT; Howell JK; Jacobs MB; Purcell JE; Norris SJ; Johnson BJ; Philipp MT
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):421-9. PubMed ID: 17596185
[TBL] [Abstract][Full Text] [Related]
11. vls Antigenic Variation Systems of Lyme Disease Borrelia: Eluding Host Immunity through both Random, Segmental Gene Conversion and Framework Heterogeneity.
Norris SJ
Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104445
[TBL] [Abstract][Full Text] [Related]
12. C-terminal invariable domain of VlsE may not serve as target for protective immune response against Borrelia burgdorferi.
Liang FT; Jacobs MB; Philipp MT
Infect Immun; 2001 Mar; 69(3):1337-43. PubMed ID: 11179296
[TBL] [Abstract][Full Text] [Related]
13. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.
Lawrenz MB; Hardham JM; Owens RT; Nowakowski J; Steere AC; Wormser GP; Norris SJ
J Clin Microbiol; 1999 Dec; 37(12):3997-4004. PubMed ID: 10565921
[TBL] [Abstract][Full Text] [Related]
14. The Borrelia burgdorferi VlsE Lipoprotein Prevents Antibody Binding to an Arthritis-Related Surface Antigen.
Lone AG; Bankhead T
Cell Rep; 2020 Mar; 30(11):3663-3670.e5. PubMed ID: 32187539
[TBL] [Abstract][Full Text] [Related]
15. Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.
Jacek E; Tang KS; Komorowski L; Ajamian M; Probst C; Stevenson B; Wormser GP; Marques AR; Alaedini A
J Immunol; 2016 Feb; 196(3):1036-43. PubMed ID: 26718339
[TBL] [Abstract][Full Text] [Related]
16. C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes.
Liang FT; Bowers LC; Philipp MT
Infect Immun; 2001 May; 69(5):3224-31. PubMed ID: 11292744
[TBL] [Abstract][Full Text] [Related]
17. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses.
Liang FT; Yan J; Mbow ML; Sviat SL; Gilmore RD; Mamula M; Fikrig E
Infect Immun; 2004 Oct; 72(10):5759-67. PubMed ID: 15385475
[TBL] [Abstract][Full Text] [Related]
18. Antigenic variation in the Lyme spirochete: detailed functional assessment of recombinational switching at vlsE in the JD1 strain of Borrelia burgdorferi.
Verhey TB; Castellanos M; Chaconas G
Mol Microbiol; 2019 Mar; 111(3):750-763. PubMed ID: 30580501
[TBL] [Abstract][Full Text] [Related]
19. Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi.
Liang FT; Philipp MT
Infect Immun; 1999 Dec; 67(12):6702-6. PubMed ID: 10569796
[TBL] [Abstract][Full Text] [Related]
20. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease.
Montgomery RR; Malawista SE; Feen KJ; Bockenstedt LK
J Exp Med; 1996 Jan; 183(1):261-9. PubMed ID: 8551229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
